发明名称 |
PIPERAZINE TRIAZINE COMPOUNDS, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS |
摘要 |
<p>The invention provides piperazine triazine compounds of Formula (I) and They're pharmaceutically acceptable salts: Formula (I) wherein: R1 is hydrogen, C1-C4alkyl, aryl, substituted aryl, aralkyl, C1-C4alkanoyl, aroyl or C3-C7cycloalkyl; R2 and R3 are respectively aryl, substituted aryl, aralkyl, C1-C4alkaryl or C3-C7cycloalkyl; X is NR7,O,S;R4 and R6 are respectively hydroxyl or C1-C6alkyl; R5 is hydroxyl, C1-C6alkyl,-C(O)R8,-(CH2)mR8,-CH2CH=CHR8,-C(O)OR8,-C(O)OR8 or S(O)2R8, m is 0,1,2 or 3; R7 is hydrogen, hydroxyl or C1-C6alkyl; R8 is hydrogen, hydroxyl, aryl, heteroaryl, heterocyclic radical or C2-C6alkenyl. It is approved that the piperazine triazine compounds of the present invention are epoxy synthase (COX-1 and COX-2) inhibitors with fine curative effect and prevention to clinic inflammation through computer virtuality screening, epoxy synthase(COX-1 and COX-2) combination experiment and pharmacological test. Preparation and pharmaceutical compositions of the compounds are also provided.</p> |
申请公布号 |
WO2005058875(A1) |
申请公布日期 |
2005.06.30 |
申请号 |
WO2004CN01368 |
申请日期 |
2004.11.29 |
申请人 |
SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES;SHANGHAI LEADDISCOVERY PHARMACEUTICAL COMPANY;JIANG, HUALIANG;LIU, HONG;SHEN, XU;ZU, XINGZU;ZHENG, MINGYUE;ZHENG, MINGFANG;JI, XINQUAN;LUO, HAIBIN;GUO, HONGXIA;LUO, XIAOMIN;SHEN, JIANHUA;CHEN, KAIXIAN |
发明人 |
JIANG, HUALIANG;LIU, HONG;SHEN, XU;ZU, XINGZU;ZHENG, MINGYUE;ZHENG, MINGFANG;JI, XINQUAN;LUO, HAIBIN;GUO, HONGXIA;LUO, XIAOMIN;SHEN, JIANHUA;CHEN, KAIXIAN |
分类号 |
A61K31/497;A61K31/53;A61P29/00;C07D251/18;C07D251/22;C07D251/38;C07D251/40;C07D251/42;C07D251/50;C07D251/52;C07D251/54;C07D403/04;(IPC1-7):C07D403/04 |
主分类号 |
A61K31/497 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|